Английская Википедия:5F-AB-PINACA
Шаблон:Short description Шаблон:Distinguish Шаблон:Drugbox
5F-AB-PINACA is an indazole-based synthetic cannabinoid that is derived from a series of compounds originally developed by Pfizer in 2009 as an analgesic medication, and has been sold online as a designer drug.[1][2]
5F-AB-PINACA has been reported to be a potent agonist of the CB1 receptor and CB2 receptor with EC50 values of 0.48 nM and 2.6 nM respectively.[3] Its metabolism has been described in literature.[4][5]
Legality
China
As of October 2015 5F-AB-PINACA is a controlled substance in China.[6]
Germany
5F-AB-PINACA is an Anlage II controlled substance in Germany as of May 2015.[7]
Singapore
It is also controlled under the Fifth Schedule of the Misuse of Drugs Act (MDA) in Singapore as of May 2015.[8]
See also
- 5F-ADB
- 5F-AMB
- 5F-CUMYL-PINACA
- AB-FUBINACA
- AB-CHFUPYCA
- AB-PINACA
- ADB-CHMINACA
- ADB-FUBINACA
- ADB-PINACA
- ADBICA
- APICA
- APINACA
- MDMB-CHMICA
- PX-3
References